We found a non-statistically significant (p > 0.05) decrease in MGMT expression (35.7 ± 16.1 vs. 13.3 ± 8.2; Supplemental Fig. 1A, B) and bcl-XL (41.3 ± 9.3 vs. 23.3 ± 5.8; Supplemental Fig. 1C) expression comparing radiation alone to radiation plus AMON in H460 NSCLC xenografts (Supplemental Fig. 1). The gene discussed is BCL2L1; the disease is non-small cell lung carcinoma.